Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis.

@article{Liao2013AdjuvantTF,
  title={Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis.},
  author={Wei-Chih Liao and Kuo-Liong Chien and Yu-Lin Lin and Ming-Shiang Wu and Jaw-Town Lin and Hsiu-Po Wang and Yu-Kang Tu},
  journal={The Lancet. Oncology},
  year={2013},
  volume={14 11},
  pages={1095-1103}
}
BACKGROUND Major adjuvant treatments for pancreatic adenocarcinoma include fluorouracil, gemcitabine, chemoradiation, and chemoradiation plus fluorouracil or gemcitabine. Since the optimum regimen remains inconclusive, we aimed to compare these treatments in terms of overall survival after tumour resection and in terms of grade 3-4 toxic effects with a systematic review and random-effects Bayesian network meta-analysis. METHODS We searched PubMed, trial registries, and related reviews and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 60 extracted citations

Similar Papers

Loading similar papers…